Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial
Besse, B., Mazières, J., Ribassin-Majed, L., Barlesi, F., Bennouna, J., Gervais, R., Moreau, L., Berard, H., Debieuvre, D., Molinier, O., Moro-Sibilot, D., Souquet, P. J., Jacquot, S., Petit, L., LenaVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx070
Date:
May, 2017
File:
PDF, 1.70 MB
english, 2017